Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004Rritual Superfoods Ready to Launch Amazon Store in USAAtai Life Sciences Is Setting The Stage For The Largest IPO The Psychedelics Sector Has Seen To DateEntheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available fMajor U.S. States Are Taking A Serious Look At Decriminalizing Psychedelic Compounds For The Treatment Of Mental IllnessMAPS Canada Is Leading The Global Charge To Commercialize Psychedelic TherapiesBetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of DirectorsMindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic MedicineTryp Therapeutics Partners with Alcami for Proprietary FormulationsHAVN Life Secures Production & Supply Agreement to Expand Retail Product OfferingsCybin Files its 12th Patent Further Strengthening IP Portfolio of Novel Psychedelic Molecules and Delivery MechanismsNuminus Wellness Is One Of The Shining Stars Of The Psychedelic SectorPsychedelic Stocks Are Starting To Get Some Serious Traction In The Mainstream MediaMAPS Canada Is Leading The Way For Psychedelic Use Cases In Modern MedicineRritual Superfoods Initiates Canadian Retail Growth Strategy Signing with Ultimate Sales CanadaNuminus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for SevTryp Therapeutics Partners with Clinlogix for Clinical Trial SupportTryp Therapeutics Partners with Fluence for Psychotherapy DesignTryp Therapeutics Announces Q2 2021 Financial ResultsRritual Announces CROSSMARK Partnership to Optimize Retail Growth
Back

Field Trip Is Shifting Gears To Expedite IPO Process

Jun 18, 2020 • 2:06 PM EDT
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

During the last month, we have noticed a significant increase in activity in the psychedelic sector and this is a trend that has caught our attention. The sector looks similar to the cannabis industry in 2016/2017 as companies are lining up to go public on a stock exchange.

Earlier this week, Field Trip announced plans to speed up the go public process and to do so has raised capital through Canaccord Genuity. When compared to its peers, we believe that the company represents an attractive growth opportunity and are favorable on the structure of the business.

A positive sign for Field Trip has been the level of the demand for its pre-IPO stock. The company’s private placement with Canaccord Genuity is definitely oversubscribed and we find this to be significant. Field Trip has been building a base of shareholders and executing on a multi-faceted growth strategy.

Field Trip represents a more advanced play on the psychedelic therapy market and is taking an integrated approach to using ketamine-enhanced psychotherapies to treat a variety of mental health conditions. The company is in the process of building out a network of clinics to initially provide ketamine-enhanced psychotherapies to treat depression.

Over the long term, Field Trip plans to expand into new therapeutics as they are approved and has plans to open 50 to 60 clinics across Canada and the US by 2023. The company has done a great job at raising capital and this aspect of the story will play a key role in its ability to execute on its strategy.

One of the reasons we are excited about Field Trip is due to the structure of the business. The company is investing in strategic verticals of the psychedelic value chain through its various divisions. The divisions are focused on opening clinics, starting clinical trials, building cultivation and processing facilities, and implementing virtual therapy.

Field Trip is led by a management team that has a proven track record of success in the cannabis clinic market and we are favorable on the expertise that they have in this field. We will monitor how the management team is able to use the proceeds from the private placements to build out its clinic network and to execute on additional high-growth initiatives.

If you are interested in learning more about Field Trip, please send an email to support@mushroomstocks.com to be added to our distribution list.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link